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Abstract
Background: A genetic knock-in mouse model expressing the R192Q mutation of the a1-subunit of the CaV2.1
channels frequently found in patients with familial hemiplegic migraine shows functional upregulation of ATP-
sensitive P2X3 receptors of trigeminal sensory neurons that transduce nociceptive inputs to the brainstem. In an
attempt to understand the basic mechanisms linked to the upregulation of P2X3 receptor activity, we investigated
the influence of the lipid domain of these trigeminal sensory neurons on receptor compartmentalization and
function.
Results: Knock-in neurons were strongly enriched with lipid rafts containing a larger fraction of P2X3 receptors at
membrane level. Pretreatment with the CaV2.1 channel blocker ω-agatoxin significantly decreased the lipid raft
content of KI membranes. After pharmacologically disrupting the cholesterol component of lipid rafts, P2X3
receptors became confined to non-raft compartments and lost their functional potentiation typically observed in KI
neurons with whole-cell patch-clamp recording. Following cholesterol depletion, all P2X3 receptor currents
decayed more rapidly and showed delayed recovery indicating that alteration of the lipid raft milieu reduced the
effectiveness of P2X3 receptor signalling and changed their desensitization process. Kinetic modeling could
reproduce the observed data when slower receptor activation was simulated and entry into desensitization was
presumed to be faster.
Conclusions: The more abundant lipid raft compartment of knock-in neurons was enriched in P2X3 receptors that
exhibited stronger functional responses. These results suggest that the membrane microenvironment of trigeminal
sensory neurons is an important factor in determining sensitization of P2X3 receptors and could contribute to a
migraine phenotype by enhancing ATP-mediated responses.
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Background
Over the last 20 years, the view of the cell plasma mem-
brane has evolved from that of a homogeneous arrange-
ment of lipids with embedded proteins towards the
notion of a mosaic of microdomains endowed with speci-
fic lipid and protein composition [1,2]. This finding led
to the definition of lipid rafts [3], namely membrane
microdomains whose major structure is made up by
sphingolipids, glycosylphosphatidylinositol (GPI)-
anchored proteins and cholesterol (insoluble in Triton X-
100 and with characteristic density fractionation; [4]).
Proteins such as Src family kinases can be found in lipid
rafts and represent potential modulators of receptors in
this compartment [5,6]. Important properties of lipid
rafts are their rapid association and dissociation [7,8], as
well as changes in their composition dependent on the
environment or the physiological state of the cell [9] or
the binding of ligands to associated receptors [10].
Growing evidence indicates that lipid rafts are crucial
for many neuronal functions, including maintenance
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and function of several ionotropic receptors for acetyl-
choline [11,12], and glutamate [13,14]. Purinergic P2X
receptors have also been found in lipid rafts [15-17].
Among them, the P2X3 receptor is almost exclusively
expressed by sensory ganglion neurons [18,19], where it
exerts an important role as transducer of pain [20].
Under basal conditions, the P2X3 subtype is a fast-
desensitizing receptor, but it can produce larger currents
under pathological pain states [20,21]. The present study
aimed at investigating whether lipid rafts might contri-
bute to the expression and function of P2X3 receptors
in sensory ganglia in a transgenic migraine mouse
model that may shed light on the mechanisms leading
to migraine.
Only a few studies looked into the association of P2X3
receptors with lipid rafts in dorsal root ganglia [15,22,23]
or recombinant expression systems such as HEK293 cells
[17]. The dynamics of this association and whether it has
functional consequences are, however, poorly under-
stood. For example, despite the fact that the lipid raft
cholesterol is depleted by treatment with methyl b-cyclo-
dextrin (MbCD; [24]), this protocol apparently leaves
P2X3 receptors unaffected [17].
Here we investigated the localization of P2X3 receptors
in sensory neurons of trigeminal ganglia (TG) from wild
type (WT) mice as well as from a genetic knock-in (KI)
mouse model that expresses an R192Q missense mutation
in the a1 subunit of CaV2.1 channels that leads to human
familial hemiplegic migraine type 1 (FHM-1; [25,26]). We
recently reported that trigeminal ganglion neurons of the
KI mice possess enhanced functional responses of P2X3
receptors without changes in their protein expression level
[27]. Hence, we explored whether P2X3 displayed differen-
tial localization between lipid rafts and the non-raft com-
partments depending on the genetic model, and whether
this redistribution might have influenced receptor function
measured as patch-clamp currents.
Results
Preferential localization of P2X3 receptors to lipid rafts of
KI trigeminal ganglion neurons
In accordance with our previous report [27], we observed
comparable expression of P2X3 receptor in WT and KI
ganglia in situ (n = 5, p > 0.05; Figure 1A middle panel).
Appearance of different gel bands (Figure 1A, left) was
accounted for by distinct states of maturation and glycosy-
lation of the receptor subunits with different gel mobility
[28,29]. Nonetheless, purification of P2X3 subunits from
WT or KI ganglia into membrane (comprising surface and
intracellular components) or the lighter cytoplasmic frac-
tions (Figure 1A right) indicated that the level of P2X3 in
membranes (calculated with respect to the total lysate)
was significantly (p = 0.007) higher for KI than WT sam-
ples (Figure 1A, right), while the opposite was observed
for the soluble cytoplasmic fraction (Figure 1A, right, p =
0.007). These data suggested distinct subcellular distribu-
tion of these receptors according to the molecular pheno-
type of KI.
We next explored if distinct membrane domains, namely
raft and non-raft fractions, were involved in such a differ-
ential expression of P2X3 receptors for WT and KI gang-
lia. Thus, we first investigated the expression of flotillin, a
canonical marker of lipid rafts [30], that was per se signifi-
cantly (p = 0.05) larger in lysates of KI ganglia with respect
to WT ones (Figure 1B). Thereafter, using sucrose density
gradient experiments and a flotillin antibody (Figure 1C),
we could detect more abundant P2X3 receptors in KI raft
fractions (bottom rows, lanes 4, 5, 6) than in WT ones
(top rows, lanes 5 and 6). Immunoprecipitation of P2X3
receptors from Triton X-100 soluble and insoluble mem-
brane preparations (corresponding to non-raft or raft
domains, respectively; Figure 1D, left), confirmed that KI
samples expressed more receptors in the raft than in the
non-raft fraction (p = 0.008; Figure 1D, right). These data
suggested differential distribution of P2X3 receptors at
membrane level with a stronger density in membrane lipid
rafts of KI ganglia. We, thus, enquired if the larger P2X3
mediated-current amplitude previously found in primary
cultures of KI trigeminal neurons [27] might be the result
of the preferential receptor segregation to this membrane
sub-domain.
A standard approach to address this issue was to dis-
rupt lipid rafts by decreasing their membrane cholesterol
content with MbCD [17,22] and to find out if the expres-
sion and function of P2X3 receptors was subsequently
changed. Hence, on cultured trigeminal neurons, label-
ling procedures for detecting lipid rafts were applied
before and after MbCD treatment (Figure 2), in which
filipin was used to detect cholesterol (Figure 2A) [22] and
FITC-conjugated cholera toxin B was used to label GM1
gangliosides expressed in lipid rafts (Figure 2B) [31].
The examples of Figure 2A show filipin staining in neu-
rons (marked by arrow in right panel) as well as in sur-
rounding satellite cells (arrow): the signal intensity was
significantly (p = 0.03) stronger for KI than WT cultures
and, in both WT and KI cultures, MbCD treatment (30
min) decreased, on average, the filipin signal intensity (p =
0.02). Nonetheless, since filipin labels cholesterol that is
widely distributed throughout cells, a more specific signal
was sought with CTX-B that also provided significantly
(p < 0.001) stronger signal from KI rather than WT cells
(Figure 2B). This signal was decreased after MbCD in both
genotypes (Figure 2B). The effective disruption of lipid
rafts by MbCD was confirmed by an altered distribution
of P2X3 receptors as exemplified by western immunoblot-
ting data (Figure 2C, left). In accordance with in situ gang-
lion results shown in Figure 1D, the P2X3 receptor signal
was larger in raft fractions (R) versus non-raft membranes
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Figure 1 Expression of P2X3 receptors in the raft domain of trigeminal neurons in situ. A, left, Examples of western immunoblots of
trigeminal ganglion lysates from WT or KI mice labeled with an anti-P2X3 antibody. Gel loading is shown with b-tubulin signal. Middle,
Histograms compare expression of P2X3 receptors in total lysates from WT and KI ganglia (n = 5). Right, Histograms quantify stronger expression
of P2X3 receptors in membrane compartments of KI samples (n = 5, p = 0.0072). Total P2X3 protein level was normalized with respect to b-
tubulin. Membrane or cytoplasmic contents were expressed a fraction of total P2X3 expression. B, left, Examples of western blots (48 kDa) of
trigeminal ganglion lysates (from WT or KI mice) immunostained with the anti-flotillin antibody. Equal gel loading is shown with b-actin signal.
Right, histograms show significant difference between WT and KI samples (n = 5, p = 0.05). C, western blotting of sucrose density gradient
fractions of trigeminal ganglion lysates from WT (top rows) or KI (bottom rows) immunostained with anti-P2X3 and anti-flotillin antibodies. Note
discrete localization of P2X3 subunits to flotillin enriched fractions. D, left, Example of western blotting of immunopurified P2X3 receptors from
membrane raft and non-raft fractions. Total input for P2X3 receptors is also shown together gel loading input with b-tubulin. Flotillin bands
indicate the raft fractions. Right, Histograms quantify significantly larger expression of P2X3 receptors in the raft fraction of KI ganglion neurons
(p = 0.008; n = 5). The P2X3 expression at cytoplasm level was significantly lower in KI samples vs WT ones (p = 0.05; n = 5).
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Figure 2 Effect of MbCD treatment on WT or KI ganglion cultures. A, Left, cholesterol staining (with filipin) of WT or KI trigeminal neurons
(arrow) before and after MbCD (30 min, 10 mM). Satellite cells (arrowhead) are also stained. Bar=10 μm. Right, fall in cholesterol staining after
MbCD (indicated by +) for WT or KI neurons (n= 55); p=0.02 for WT before and after MbCD; p=0.03 for untreated WT vs untreated KI; p=0.01 for
KI before and after MbCD. B, CTX-B staining of WT and KI trigeminal neurons before and after MbCD. Bar=10 μm. Right, Large reduction in CTX-B
staining after MbCD in WT (p<0.001) and in KI cells (p<0.001). The CTX-B staining of untreated KI cells was significantly larger vs untreated WT
neurons (p<0.002); n=62 cells. C, Raft (R) and non rafts (NR) fractions from WT and KI lysates before or after MbCD. Non raft fractions were
cytosolic samples collected from supernatants after ultracentrifugation with a swing bucket rotor. Conversely, membrane pellets labelled with
flotillin were considered to be raft fractions. Immunolabelling was performed with anti-P2X3 receptor and anti-flotillin antibodies. The histograms
(right) quantify the distribution of P2X3 receptors to raft and non- raft compartments of WT or KI cultures: the raft fractions of KI was
significantly larger than the corresponding WT ones (*: p=0.004, n=3). After 30 min application of MbCD there was redistribution of P2X3
receptors to cytosolic fractions of WT or KI samples. ** indicates p=0.0038, while *** indicates p=0.001 (n=3). D, example of immunoblotting of
P2X3 receptors from supernatants and pellets collected after ultracentrifugation with a fixed angle rotor. The flotillin labelled membrane fractions
of KI cultures were largely decreased by overnight pretreatment with ω-agatoxin (300 nM; selective blocker of P/Q channels) as indicated by the
histograms (right; * shows p=0.02, n=4).
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(NR) from KI cultures with respect to WT (Figure 2C,
right). Furthermore, as a consequence of lipid disruption
by MbCD pre-treatment, a significant redistribution of
P2X3 receptor expression was observed in NR fractions of
both WT and KI samples (Figure 2C, right). The P/Q
channel blocker ω-agatoxin (300 nM; overnight) caused
strong reduction in the lipid raft membrane fraction of KI
cells without a significant change in the WT ones (Figure
2D, p = 0.02, n = 4), thus linking the CaV2.1 gain-of-func-
tion to the larger lipid raft expression by KI membranes.
In summary, our data concur to indicate that KI neu-
rons were enriched with lipid rafts where the major
fraction of membrane P2X3 receptors was present.
Lipid rafts dependent modulation of P2X3 receptor
function
Patch-clamp recording allowed us to study whether the
differential distribution of P2X3 receptors between WT
and KI neurons might have a functional consequence.
To this end, we compared the effect of MbCD pretreat-
ment on WT and KI neurons whose P2X3 receptors
were activated to produce large and fast decaying
inward currents by a pulse of a,b-methylene ATP (a,b-
meATP; 10 μM), a selective agonist of this receptor
subtype [32], as exemplified in Figure 3A. On average,
we first confirmed that the peak amplitude of KI cur-
rents was larger than the WT ones (520 ± 58 vs. 338 ±
26 pA, n = 33; p = 0.006). Although MbCD did not sig-
nificantly change neuronal input resistance (420 ± 66
and 430 ± 71 MΩ before and after MbCD), it did, how-
ever, decrease the peak amplitude of a,b-meATP
mediated currents (p = 0.008 for WT and p = 0.002 for
KI) by about 30% for WT and 44% for KI cells to simi-
lar values (Figure 3A, B).
MbCD application led to changes in cell capacitance:
from 32 ± 2 to 20 ± 2 pF for WT (p < 0.001), and from
29 ± 2 to 23 ± 2 for KI (p = 0.04). Thus, we also calculated
the responses evoked by a,b-meATP (10 μM) in terms of
current density rather than peak amplitude. Hence, con-
trol WT responses were, on average, 11.7 ± 1.1 pA/pF
(n = 30), while KI responses were 18.1 ± 1.7 pA/pF (n =
30; p = 0.003). Following MbCD application, the corre-
sponding values were 13.8 ± 1.6 pA/pF (n = 22) for WT
and 14.5 ± 1.4 pA/pF for KI (n = 24; p = 0.74) for KI neu-
rons. Hence, the significant difference in P2X3 receptor
mediated responses between WT and KI neurons was lost
after MbCD application.
Figure 3C compares examples (on a faster time base) of
scaled and superimposed currents recorded before and
after MbCD application. For both WT and KI responses,
there was a clear acceleration of the slow component of
current decay. Figure 4 shows that neither the current
onset (A) nor the fast current decay (τfast, B) was changed
by MbCD. However, the slow decay of the current
(measured as τslow; Figure 4C) was accelerated, likely
reflecting changes in late phases of receptor desensitiza-
tion [33]. This process can explain the delayed recovery
from desensitization (Figure 4D; tested with the standard
Figure 3 Patch clamp recording from WT and KI cultured
neurons. A, Representative current traces evoked by a,b-meATP (10
μM, 2 s) from WT and KI neurons in control and after MbCD pre-
treatment (30 min, 10 mM). B, Histograms quantify the current
amplitude before or after MbCD pre-treatment for WT and KI
neurons. Control: n = 33 for WT and KI. *: p = 0.006. **:p = 0.008;
***: p = 0.002. MbCD: n = 30 for WT and KI. C, P2X3 mediated
current traces (average of 14-20 responses) in control (black) and
after MbCD pre-treatment (gray), normalized and overlapped, from
WT (left) and KI (right) neurons. Note no change in the current
onset, and clear acceleration of its slow decay.
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protocol of two paired pulses of a,b-meATP spaced 30 s
apart; [27,33]). These data suggest that depletion of cho-
lesterol by MbCD led to diminished P2X3 receptor cur-
rent amplitude with accelerated desensitization and
slower recovery from it in WT and KI neurons.
Kinetic modeling of the P2X3 receptor changes following
MbCD application
We next explored the changes in the functional activity
of the P2X3 receptors by using a cyclic kinetic model of
receptor operation in which various phases of activation
and desensitization are included (see Figure 5A; [33]). In
the case of P2X3 receptors, kinetic modelling is advanta-
geous to explore certain receptor operation steps which
develop very rapidly and are readily obscured by inter-
vening desensitization, making quite difficult to extract
detailed information from single channel studies [33,34].
Hence, by optimization of the rate constants in this
kinetic model (see Materials and Methods), we could
adequately simulate a,b-meATP (10 μM) evoked cur-
rents in terms of experimental amplitude, current onset,
desensitization time constants (τfast and τslow), and the
degree of recovery from desensitization tested 30 s later
(Figure 5B). The corresponding rate constants are pro-
vided in Table 1. It should be noted that these values
are the rate constants optimized to simulate the present
mouse trigeminal neuron data as the original model was
derived from rat P2X3 receptors of dorsal ganglion neu-
rons [33]. Once the actual currents observed with
patch-clamping were closely replicated by the model,
changes in discrete reaction steps were tested. Figure 5C
shows how changes in the values of rate constants con-
trolling the process of receptor activation and desensiti-
zation could closely replicate all the effects observed
experimentally after MbCD without affecting parameters
like the current onset or its fast desensitization (see
Figure 4). In particular, reduced current amplitude
was produced by decreasing the rate constant k4 (see
Figure 5A and Table 1) to slow down gating of the
active fully-bound receptor. This simple change, how-
ever, was associated with slower current decay (not
shown) rather than the faster decline observed experi-
mentally. Thus, to closely mimic the accelerated decay
of the slow current component together with smaller
recovery from desensitization, we increased the rate
constant d5 of receptor transition from the open bound
state A3Ro to the rapidly desensitizing A3Df as well as
the rate constant n4 from the A3Df state to the slower
desensitizing bound state A3D.
Discussion
The principal finding of this study is the novel demon-
stration that in KI mice P2X3 receptors of trigeminal
neurons are preferentially localized to lipid rafts, a phe-
nomenon associated with a molecular phenotype charac-
terised by stronger responses to P2X3 receptor
activation [27]. Because altering lipid rafts was translated
into less efficient P2X3 receptor mediated responses, our
data suggest that P2X3 receptor compartmentalization
Figure 4 Properties of P2X3 receptor mediated responses of
WT and KI neurons. Histograms quantify the different properties of
P2X3 receptors in WT (left) or KI (right) trigeminal neurons in control
and after MbCD treatments. Note that MbCD treatment accelerates
the slow desensitization time constant and slows down the degree
of recovery from desensitization in WT and KI neurons (tested at 30
s interval). Data refer to effects induced by 10 μM a,b-meATP. A,
current onset expressed as 10-90% response rise time. Control: n =
20 for WT and n = 25 for KI. MbCD: n = 15, p > 0.05 for WT; n = 27,
p > 0.05 for KI. B, desensitization onset (fast desensitization time
constant, τfast) Control: n = 18 for WT and n = 20 for KI. MbCD: n =
12, p > 0.05 for WT and n = 24, p > 0.05 for KI. C, retarded current
decay (slow desensitization time constant, τslow). Control: n = 18 for
WT and n = 20 for KI. MbCD: n = 11, p < 0.01 for WT and n = 21, p
= 0.04 for KI. D, recovery from desensitization, expressed as % of
control response amplitude with 30 s paired pulse protocol of a,b-
meATP application. Control: n = 12 for WT and n = 16 for KI. MbCD:
n = 7, p = 0.03 for WT and n = 11, p < 0.01 for KI.
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Figure 5 Modeling changes in P2X3 receptor activity after MbCD. A, Scheme of the cyclic model of P2X3 operation with reversible multi
step process adapted from [33]. A, agonist (suffix values indicate the number of bound molecules); R, resting state; A3Ro, fully-occupied open
state; A3Df, rapidly desensitizing state; ARn and ADn, bound non activated and desensitized states, respectively, with corresponding number of
bound agonist molecules. Forward rate constants for activation are indicated as k, while reverse rate constants are indicated by l. The process of
desensitization is indicated by n or m constants depending on the reaction direction. Intermediate transitions from each one of the upper and
lower branch states are possible with rate constants indicated as r or d. For the purpose of simulating the actual experimental conditions
observed with rapid, short pulse of agonist application at high concentration, the scheme is envisaged to primarily follow the R, A3Ro, A3Df, D
pathway. Rate constant values are provided in Table 1 after adapting data from rat dorsal root ganglion neurons [33]. B, Simulated responses
evoked by paired pulses of a,b-meATP (10 μM, 2 s; 30 s interval) in control condition. The amplitude of the second response recovers to 24% of
the first one, in analogy with experimental data. C, Similar protocol simulated after MbCD treatment. Note that the current amplitude is
diminished, and the current decay is faster, while recovery from desensitization is impaired. The vertical calibration bar refers to the fraction of
active receptors.
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at membrane level contributed to the larger ATP signal-
ling by KI neurons.
A phenotype with gain-of-function of P2X3 receptors
contained a larger membrane lipid raft domain
KI trigeminal neurons carrying the R192Q missense
mutation in the a1 subunit of CaV2.1 channels are
known to express enhanced P2X3 receptor activity [27]:
this phenomenon is attributed to the larger intracellular
Ca2+ levels mediated by hyperfunctional CaV2.1 channels
(P/Q type) and a consequent change in P2X3 receptor
phosphorylation state without alteration in their total
membrane expression. The present investigation
expanded these findings by adding that KI neurons had
significantly larger association of P2X3 receptors to the
lipid raft compartment. This association might have
important functional implications because lipid rafts can
form concentrating platforms for individual receptors
activated by ligand binding [35]. For instance, distinct
intracellular signalling pathways have been proposed for
P2X7 receptors when distributed to raft or non-raft
domains [36]. Previous studies have indicated that
CaV2.1 channels are particularly clustered in lipid
microdomains [37], thereby placing them in a strategic
position to directly modulate lipid rafts and their asso-
ciated P2X3 receptors. In support of this notion, the pre-
sent report showed that there was a significant decrease
in the membrane lipid raft fraction of KI samples after
pretreatment with the CaV2.1 channel blocker ω-aga-
toxin. It seems, therefore, likely that the gain of function
of mutated CaV2.1 channels led to upregulated lipid raft
expression by KI cells. Nonetheless, the present report
does not exclude the possibility that increased intracellu-
lar Ca2+ due to the mutated channels might have also
operated via intracellular pathways [20] to functionally
modify P2X3 receptors resident in raft domains.
To investigate the impact of lipid rafts on P2X3 recep-
tor activity, we tested the consequences of altering the
composition of lipid rafts with MbCD. We detected, after
such a treatment to trigeminal neurons, a small reduction
in cholesterol (labelled with filipin that marks all choles-
terol stores), and a more evident decrease in CTX-B posi-
tive domains (corresponding to membrane lipid rafts).
These data, thus, suggested that lipid rafts were pivotal to
determine stronger P2X3 receptor activity of KI neurons.
To further test this hypothesis, we decided to decrease
lipid rafts and their P2X3 content, and to find out if
P2X3 receptor function of KI neurons reverted to the
WT phenotype.
Functional changes of P2X3 receptors evoked by altering
lipid rafts
Electrophysiological studies showed similar impairment
in the function of P2X3 both in WT and KI after
MbCD treatment. Thus, the mere presence of P2X3
receptors in lipid rafts did not confer them special
intrinsic properties, rather it favoured their assembly
within a macromolecular structure that possibly contrib-
uted to the global cell responses constitutively larger in
KI neurons [27]. It seems, therefore, likely that the more
abundant lipid rafts of KI neuronal membranes simply
created a more favourable environment to express P2X3
receptors and to maximize their activity. This notion
accords with the suggestion that lipid rafts provide a
spatial and temporal meeting point for signalling mole-
cules, as they contain a number of proteins that might
be transiently or permanently associated with ion chan-
nels [38,39]. Channel function can be modulated by
lipid rafts in a number of different ways through direct
lipid-protein interactions or by altering the biophysical
properties of the lipid bilayer. For instance, in the field
of purinergic receptors, phosphoinositides can modulate
the function of P2X3 [40] and P2X4 receptors by inter-
acting with their C-terminal [41]. In addition, lipid rafts
may be the milieu to promote receptor trafficking and
internalization [23]. Notwithstanding the need to clarify
the molecular interactions between P2X3 receptors and
Table 1 Values of rate constants of P2X3 receptor kinetic
model in mouse trigeminal neurons
Rate Constant Control + MbCD
k1 24000 (mM-1·s-1) 24000 (mM-1·s-1)
l1 15 (s-1) 15 (s-1)
k2 16000 (mM-1·s-1) 16000 (mM-1·s-1)
l2 30 (s-1) 30 (s-1)
k3 8000 (mM-1·s-1) 8000 (mM-1·s-1)
l3 45 (s-1) 45 (s-1)
k4 75 (s-1) 40 (s-1)
l4 10 (s-1) 10 (s-1)
m1 24000 (mM-1·s-1) 24000 (mM-1·s-1)
n1 0.01 (s-1) 0.019 (s-1)
m2 16000 (mM-1·s-1) 16000 (mM-1·s-1)
n2 0.02 (s-1) 0.038 (s-1)
m3 8000 (mM-1·s-1) 8000 (mM-1·s-1)
n3 0.03 (s-1) 0.057 (s-1)
m4 0.001 (s-1) 0.001 (s-1)
n4 0.44 (s-1) 0.68 (s-1)
d1 0.00001 (s-1) 0.00001 (s-1)
r1 10 (s-1) 10 (s-1)
d2 0.12 (s-1) 0.12 (s-1)
r2 0.00001 (s-1) 0.00001 (s-1)
d3 0.00001 (s-1) 0.00001 (s-1)
r3 0.00001 (s-1) 0.00001 (s-1)
d4 0.00001 (s-1) 0.00001 (s-1)
r4 0.00001 (s-1) 0.00001 (s-1)
d5 9.0 (s-1) 13.0 (s-1)
r5 1.1 (s-1) 1.1 (s-1)
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lipid rafts with future studies, the present report pro-
vides evidence that the MbCD-induced alteration in
lipid rafts was accompanied by changes in the current
amplitude and desensitization of P2X3 receptors.
Because cholesterol is an essential component of cell
membranes, it was not surprising that MbCD could
decrease the cell capacitance. Even when data were cal-
culated in terms of current density to take this change
into consideration, there was no significant difference
between WT and KI responses following MbCD applica-
tion. Thus, non-raft P2X3 receptors whether of WT or
KI cells appeared to share similar effectiveness, leading
to the suggestion that the milieu of the lipid raft domain
likely conferred stronger activity to P2X3 receptors. As
lipid rafts were more abundant in KI neurons, they,
therefore, represented an important substrate to facili-
tate P2X3 receptor mediated responses. Recombinant
P2X3 receptors expressed by HEK cells did not appar-
ently change their function after MbCD [17]; the discre-
pancy from the present native receptors might be
attributed to differences in the lipid raft compartments
of HEK cells versus sensory ganglion neurons.
Non-specific changes in cell properties could not
account for the stronger receptor desensitization because
smaller size responses (due to the activity of fewer recep-
tors) are normally associated with less desensitization
[33,42]. Indeed, our kinetic model showed that simulat-
ing only impaired receptor activation was translated into
slower response decay, unlike the faster current decay
actually detected experimentally.
Previous studies of ligand-gated receptors have exploited
kinetic modelling to unravel conformational states that
cannot be resolved at the macroscopic level and to provide
a detailed mechanism of channel activation [43]. In the
case of P2X3 receptors with fast activation and desensiti-
zation, kinetic modelling contributes to the understanding
of these mechanisms by revealing additional information
that is not readily available from single-channel recording.
Indeed, kinetic modelling has largely helped to clarify
detailed operation, for example, of glutamate [44,45],
P2X2 [46] or nicotinic receptors [47]. The cyclic scheme
of P2X3 receptor operation has been subsequently refined
by including an allosteric mechanism useful to account
for the phenomenon of very slow desensitization evoked
by ambient ATP [34]. Because the present report was
focussed on rapid responses induced by pulse application
of a,b-meATP, it was felt unnecessary introducing these
additional steps. The use of this kinetic model remains, of
course, a simplification of the receptor operational mode
useful to supply a scheme compatible with the interpreta-
tion of the observed results. Reducing the rate constant
controlling the isomerization of the fully-occupied recep-
tor could reproduce the smaller amplitude without chan-
ging the response onset. Furthermore, faster transition
from active to the desensitized receptor state replicated
the accelerated current decay.
These observations closely resemble the behaviour
described for GABAA receptors when their lipid micro-
environment is perturbed with consequent loss of
response amplitude and increased rate of desensitization
[48]. Likewise, lipid microenvironment in form of “shell”
or “annular” lipids has a strong effect on the structural
and functional properties of the nicotinic receptors
[49-51] as cholesterol is an absolute requirement for
their stability, supramolecular organization and function
[52-54].
Conclusions
The present study reports the novel finding that KI neu-
rons expressing a genetic mutation associated with
familial hemiplegic migraine were enriched in their
membrane microdomain of lipid rafts where P2X3
receptors were predominantly housed. The stronger
association of such receptors with lipid rafts had the
functional consequence of evoking larger responses
mediated by these nociceptors that are important trans-
ducers of acute trigeminal pain.
Materials and methods
Genetic Model
CaV2.1 a1 R192Q mutant KI and WT littermates were
used for the experiments. Genotyping was routinely per-
formed as previously described [25,27]. Homozygous
R192Q KI and WT littermates used for this study share
the same genetic background (~97% C57Bl6J back-
ground), as described in van den Maagdenberg et al [25],
and originally backcrossed for five generations followed
by further in-house backcrossing to preserve the original
phenotype. All procedures were approved by the local
ethical committee for animal experimentation in accor-
dance with guidelines of the International Association for
the Study of Pain. Animals were maintained in accor-
dance with the Italian Animal Welfare Act and their use
was approved by the Local Authority Veterinary Service.
Cell culture preparation of TG neurons
Trigeminal ganglia primary cultures from KI and WT
mice were prepared as previously described (P10-14),
and used after 24 h from plating [29,55].
Membrane protein extraction
For total membrane protein extraction, trigeminal ganglia
were lysed in phosphate saline buffer (PBS) containing
Triton X-100 1%, 100 mM NaF, 20 mM orthovanadate
plus the protease inhibitors cocktail (Sigma, Milan, Italy),
incubated on ice for 45 min and centrifuged for 20 min at
10,000 g at 4°C. Total ganglia membranes were subjected
to ultracentrifugation at 100,000 g for 1 h (4°C) with a
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fixed-angle rotor [56,57]. Triton-insoluble membrane pel-
lets were dissolved in sample buffer (100 mM Tris-HCl
pH 6.8, 200 mM dithiothreitol, 4% SDS, 20% glycerol, 8 M
urea) and separated on 8% polyacrylamide gel, and repre-
sented the raft fraction. The remaining supernatant
(Triton-soluble) was defined as non raft fraction.
To ensure correct equal loading for neuronal cell con-
tent in different lysates, protein extracts were quantified
with bicinchonic acid (Sigma) and normalized for the
neuronal specific b-tubulin III. The amount of loaded
proteins was in the 20-50 μg/mL range. Immunoprecipi-
tation of P2X3 receptors from the two fractions (raft
and non-raft) was performed as described earlier [57].
b-tubulin or b-actin were used for gel loading reference.
Sucrose density gradient preparation
Sucrose density gradients were prepared as described pre-
viously [58]. Briefly, cells were lysed in TNE buffer
(10 mM Tris HCl pH 7.4, 150 mM NaCl, 2 mM EDTA,
20 mM NaF, 20 mM orthovanadate) plus protease inhibi-
tors (30 min on ice) followed by sonication; insoluble
membrane proteins were purified by ultracentrifugation
(100,000 g for 60 min at 4°C). Pellets were resuspended in
500 mM Na2CO3, and added to 25 mM 2-N-morpholino
ethanesulfonic acid (MES buffer), 150 mM NaCl, at pH 6,
with 90% sucrose and protease inhibitors to reach a final
dilution of 45% sucrose. The lysate was transferred to a
TLS55 ultracentrifuge tube with a swing-bucket rotor to
separate lipid rafts [15], and layered sequentially with 90,
45 and 5% sucrose in MES buffer. Samples were centri-
fuged at 200,000 g for 16 h and 100 μl fractions were col-
lected from the top. 1% CHAPS was added to each
fraction (to allow correct migration in western blotting)
that was diluted with TNE buffer (1:5) and kept for
45 min on ice. Proteins were concentrated by centrifuga-
tion at 13,000 g for 30 min at 4°C. Final pellets were resus-
pended in sample buffer (100 mM Tris-HCl pH 6.8,
200 mM dithiothreitol, 4% SDS, 20% glycerol, 8 M urea)
and separated on 8% polyacrylamide gel.
Western immunoblotting
Western immunoblotting was performed using the fol-
lowing antibodies: rabbit anti-P2X3 (1:300; Alomone,
Jerusalem. Israel), mouse anti-flotillin 1 (1:250, BD Bios-
ciences, Franklin Lakes, NJ, USA), mouse anti b-actin
(specific HRP-conjugated; dilution 1:1000; Sigma) and
mouse b-tubulin III (1:1000, Sigma).
As secondary antibodies, to avoid detection of immu-
noglobulin heavy chains in Western blot, previously-
validated HRP-conjugated antibodies (Jackson Immu-
noResearch, Suffolk, UK) were used [57]. Signals were
detected with the enhanced chemiluminescence light
system ECL (Amersham Biosciences, Piscataway, NJ).
For quantification of intensities of the immunoreactive
protein bands we used Scion Image software (NIH,
Bethesda, USA) or the digital imaging system UVTEC
(Cambridge, UK).
Cholesterol and rafts labelling
Cholesterol distribution in cultured trigeminal neurons
was analyzed using a cell based cholesterol assay kit
(Cayman, Ann Arbor, MI) [59,60], based on filipin stain-
ing (5 μg/mL, 10-20 min), a compound that forms fluor-
escent complexes with unesterified cholesterol [22].
For detection of lipid rafts, paraformaldehyde fixed tri-
geminal neurons were washed with PBS and incubated for
30 min with blocking solution (5% FCS, 5% BSA, 0.1% Tri-
ton-X) followed by 3 times washout with PBS, and then
incubated with FITC conjugated cholera toxin B subunit
(3 μg/mL; Sigma) for 10 min and then washed thrice with
PBS. Labelled cells were viewed with a Zeiss microscope
and acquired with MetaView software (Molecular Devices,
Downingtown, PA, USA) in non-saturation mode. To
quantify data, basal threshold was arbitrarily set to zero,
and grey values were then analyzed with MetaMorph soft-
ware (Molecular Devices, Downingtown, PA, USA).
Response intensity was evaluated for each cell from each
region of interest (0.075 mm2) and expressed as arbitrary
units (AU). An average of fifty cells was analyzed in each
test; data are the mean of at least three independent
experiments.
Patch Clamp Recording
Currents were recorded from mouse trigeminal neurons in
culture as previously described [27] under whole cell vol-
tage clamp mode at a holding potential of -60 mV. Cells
were continuously superfused with control solution con-
taining (in mM): 152 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2,
10 glucose, 10 HEPES; pH 7.4 adjusted with NaOH. Patch
pipettes had resistance of 3-4 MΩ when filled with (in
mM): 140 KCl, 2 MgCl2, 0.5 CaCl2, 2 ATP-Mg, 2 GTP-Li,
20 HEPES, 5 EGTA; pH 7.2 adjusted with KOH. Data
were acquired and analyzed with the pCLAMP software
Clampex 9.2 (Molecular Devices, Palo Alto, CA, USA).
Drug application
The agonist a,b-meATP (Sigma) was applied for 2 s by
rapid solution changer system (Perfusion Fast-Step Sys-
tem SF-77B, Warmer Instruments, Hamden, CT, USA).
The cholesterol depleting agent methyl-b-cyclodextrin
(MbCD; Sigma) was dissolved in water and then applied
to the cells in culture at the concentration of 10 mM
for 30 min in the cell incubator in accordance with pre-
vious reports [22,61]. Electrophysiological recordings
started after 10 min of wash with control solution and
continued for approximately 1 h. This protocol of
MbCD application increased the holding current of
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patch-clamped neurons from -50 ± 9 to -85 ± 9 pA (n =
65 and 49; p = 0.01).
Data Analysis
The currents were analyzed in terms of their peak
amplitude and current onset (10-90% of the response
rise-time). The decay of the current during agonist
application due to receptor desensitization was fitted
with a biexponential function using Origin 6.0 (Micro-
cal, Northampton, MA, USA) which provided the desen-
sitization time constants (τfast and τslow). Recovery from
desensitization was assessed by a paired pulse protocol
over 30 s intervals in accordance with previous reports
[27,55].
All data are presented as mean ± standard error of the
mean (S.E.M); n is number of cells. Statistical signifi-
cance was evaluated with unpaired Student’s t-test (for
parametric data) or Mann-Whitney-Wilcoxon test (for
nonparametric data), p ≤ 0.05 was considered
significant.
Kinetic modeling
Kinetics of the P2X3 receptor mediated currents was
simulated using the cyclic Markov state model [33]
shown in Figure 5A. It assumes the binding of the three
molecules of the agonist to the receptor in the resting
state R, the isomerisation of the receptor into the open
state Ro, followed by transition into the rapidly develop-
ing desensitized state Df, and the slower occurring
desensitized-bound state A3D with slow agonist disso-
ciation. Standard desensitization is inferred to develop
from open bound channels A3Ro.
In total, in the model there are 10 states and 26 rate
constants. The original model used rate constants applied
to membrane currents recorded from rat dorsal root
ganglion neurons. To adapt this scheme to trigeminal
mouse sensory neurons that possess distinct time-course
of desensitization and recovery [29], manual optimization
of the rate constants was performed, using a PC, with our
in-house developed program [33] written in Delphi.
Hence, the peak amplitude, onset and decay time con-
stants and recovery of the a,b-meATP induced P2X3
receptor mediated currents in control conditions and
after cholesterol depletion with MbCD were obtained
with the rate constant values indicated in Table 1 to
reproduce the experimentally-obtained records. As we
observed a comparable experimental change in WT and
KI responses after MbCD, only simulation of the WT
currents is shown.
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